Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's CancerJung-Min Lee, Cody J Peer, Minshu Yu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 20, 2020
Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing RegimenEleanor Jing Yi Cheong, Pramod C Nair, Rebecca Wan Yi Neo, et al.
Molecular Cancer Research : MCR|September 15, 2021
Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma ModelAmélie Vézina, Monica Manglani, DreeAnna Morris, et al.
Pediatric Blood & Cancer|August 12, 2021
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumorsHolly J Meany, Brigitte C Widemann, Pamela S Hinds, et al.
Molecular Cancer Therapeutics|November 5, 2021
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRAS Mutant RhabdomyosarcomaNatalia Garcia, Vanessa Del Pozo, Marielle E Yohe, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicityMichele Ceribelli, Frances Anne Tosto, Xiaohu Zhang, et al.
Pharmacogenetics and Genomics|November 1, 2012
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel responseJoshua P Lewis, Richard B Horenstein, Kathleen Ryan, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2014
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphomaJonathan L Berkowitz, John E Janik, Donn M Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2014
A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational studyAnish Thomas, Arun Rajan, Eva Szabo, et al.
Pageof 16